Sign in

CIK 0001790340

  • Emerging growth company

Immuneering Corp

Sign in to watch
Ticker
IMRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-500-8080
Business address
245 MAIN STREET, SECOND FLOOR, CAMBRIDGE, MA, 02142
Open-market buys, last 90 days
$89,500
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$89,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Gengos Andrew +$90K Chief Financial Officer 1 filing
Date Insider Transaction Shares Price Value Owned after
2022-06-21 KEATING LAURIE Director Grant or award · Stock Option +14,200 14,200
2022-06-21 HAUSMAN DIANA Director Grant or award · Stock Option +6,185 6,185
2022-05-25 Hall Brett Matthew CHIEF SCIENTIFIC OFFICER Purchase +2,551 $3.92 $10K 332,685
2022-05-17 Bookman Michael GENERAL COUNSEL AND SECRETARY Purchase +1,000 $4.88 $5K 2,402
2022-05-16 KEATING LAURIE Director Purchase +7,000 $5.00 $35K 14,000
2022-05-12 Amin Biren CFO, TREASURER Purchase +1,000 $4.42 $4K 7,898
2022-04-12 Zeskind Benjamin J. PRESIDENT AND CEO Exercise or conversion +2,000 $3.01 $6K 2,259,352
2022-04-12 Zeskind Benjamin J. PRESIDENT AND CEO Exercise or conversion · Stock Option −2,000 206,000
2022-03-23 Zeskind Benjamin J. PRESIDENT AND CEO Purchase +3,000 $8.02 $24K 2,257,352
2022-03-23 Hall Brett Matthew CHIEF SCIENTIFIC OFFICER Purchase +1,050 $7.91 $8K 330,134
2022-03-22 Barrett Scott CHIEF MEDICAL OFFICER Purchase +900 $7.49 $7K 7,563
2022-03-15 Feinberg Peter Director Purchase +6,667 $6.75 $45K 11,766
2022-03-15 BERMAN ANN E Director Purchase +6,000 $6.40 $38K 9,500
2022-02-28 Zeskind Benjamin J. PRESIDENT AND CEO Exercise or conversion +2,000 $3.01 $6K 2,254,352
2022-02-28 Zeskind Benjamin J. PRESIDENT AND CEO Exercise or conversion · Stock Option −2,000 208,000
2022-02-10 Amin Biren CFO, TREASURER Grant or award · Stock Option +70,050 70,050
2022-02-10 Hall Brett Matthew CHIEF SCIENTIFIC OFFICER Grant or award · Stock Option +83,100 83,100
2022-02-10 Barrett Scott CHIEF MEDICAL OFFICER Grant or award · Stock Option +71,850 71,850
2022-02-10 Bookman Michael GENERAL COUNSEL AND SECRETARY Grant or award · Stock Option +47,300 47,300
2022-02-10 Zeskind Benjamin J. PRESIDENT AND CEO Grant or award · Stock Option +156,485 156,485

Page 9 of 12 · 226 trades